Procedure Volume by Procedure Type - Oncology, Neurology
and Cardiology (In 000s) (includes corresponding
Graph/Chart) II-33
Table 10: US FDG Radiopharmacy Market: Number of Doses,
Unit Cost and Number of Nuclear Pharmacies for 2004, 2008 &
2012(P) (includes corresponding Graph/Chart) II-33
Focused R&D Efforts will Fuel Therapeutic
Radiopharmaceuticals Market II-34
Market Share Statistics II-34
Table 11: US Market for Diagnostics Radiopharmaceuticals
Agents (2007): Percentage Share Breakdown of Value Sales by
Leading Players - Lantheus Medical Imaging, GE HealthCare,
Mallinckrodt and Others (includes corresponding
Graph/Chart) II-34
Table 12: US Market for Cardiology Diagnostic
Radiopharmaceutical Agents (2007): Percentage Share
Breakdown of Value Sales by Leading Players - Lantheus
Medical Imaging, GE HealthCare and Others (includes
corresponding Graph/Chart) II-34
Table 13: US Market for Non-Cardiology Diagnostic
Radiopharmaceutical Agents (2007): Percentage Share
Breakdown of Value Sales by Leading Players - Mallinckrodt,
GE HealthCare, Lantheus Medical Imaging and Others
(includes corresponding Graph/Chart) II-35
Table 14: US Market for Therapeutic Radiopharmaceuticals
(2007): Percentage Share Breakdown of Value Sales by Key
Radiotherapeutics - Bone Palliation, Non-Hodgkin's
Lymphoma, Hyperthyroidism /Thyroid Cancer and Others
(includes corresponding Graph/Chart) II-35
Table 15: US Market for Therapeutic Radiopharmaceutical
Agents (2007): Percentage Share Breakdown of Value Sales by
Leading Players - GE HealthCare, Mallinckrodt, Biogen-Idec,
GlaxoSmithKline, Cytogen and Others (includes
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |